Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Assessment of spatial heterogeneity in continuous twin screw wet granulation process using three-compartmental population balance model.

Liu H, Galbraith SC, Park SY, Cha B, Huang Z, Meyer RF, Flamm MH, O'Connor T, Lee S, Yoon S.

Pharm Dev Technol. 2019 Jan;24(1):105-117. doi: 10.1080/10837450.2018.1427106. Epub 2018 Jan 25.

PMID:
29336653
2.

Achieving Continuous Manufacturing for Final Dosage Formation: Challenges and How to Meet Them May 20-21 2014 Continuous Manufacturing Symposium.

Byrn S, Futran M, Thomas H, Jayjock E, Maron N, Meyer RF, Myerson AS, Thien MP, Trout BL.

J Pharm Sci. 2015 Mar;104(3):792-802. doi: 10.1002/jps.24247. Epub 2016 Jan 8.

PMID:
28756841
3.

Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.

Byrn S, Futran M, Thomas H, Jayjock E, Maron N, Meyer RF, Myerson AS, Thien MP, Trout BL.

J Pharm Sci. 2015 Mar;104(3):792-802. doi: 10.1002/jps.24247. Epub 2014 Dec 12. Review.

PMID:
25501530
4.

Producing monodisperse drug-loaded polymer microspheres via cross-flow membrane emulsification: the effects of polymers and surfactants.

Meyer RF, Rogers WB, McClendon MT, Crocker JC.

Langmuir. 2010 Sep 21;26(18):14479-87. doi: 10.1021/la1023136.

PMID:
20731340
5.

A rapid method for creating drug implants: translating laboratory-based methods into a scalable manufacturing process.

Wang CK, Wang WY, Meyer RF, Liang Y, Winey KI, Siegel SJ.

J Biomed Mater Res B Appl Biomater. 2010 May;93(2):562-72. doi: 10.1002/jbm.b.31617.

6.

A comprehensive approach for the determination of extractable and leachable metals in pharmaceutical products by inductively-coupled plasma.

Zuccarello DJ, Murphy MP, Meyer RF, Winslow PA.

PDA J Pharm Sci Technol. 2009 Jul-Aug;63(4):339-52.

PMID:
20088247
7.

Universal dripping and jetting in a transverse shear flow.

Meyer RF, Crocker JC.

Phys Rev Lett. 2009 May 15;102(19):194501. Epub 2009 May 12.

PMID:
19518958
8.

Gamma irradiation can be used to inactivate Bacillus anthracis spores without compromising the sensitivity of diagnostic assays.

Dauphin LA, Newton BR, Rasmussen MV, Meyer RF, Bowen MD.

Appl Environ Microbiol. 2008 Jul;74(14):4427-33. doi: 10.1128/AEM.00557-08. Epub 2008 May 30.

9.

Impact of irrigation on larval density of stem-infesting pests of cultivated sunflower in Kansas.

Charlet LD, Aiken RM, Meyer RF, Gebre-Amlak A.

J Econ Entomol. 2007 Oct;100(5):1555-9.

PMID:
17972632
10.
11.

A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor.

Walsh JJ, Pesik N, Quinn CP, Urdaneta V, Dykewicz CA, Boyer AE, Guarner J, Wilkins P, Norville KJ, Barr JR, Zaki SR, Patel JB, Reagan SP, Pirkle JL, Treadwell TA, Messonnier NR, Rotz LD, Meyer RF, Stephens DS.

Clin Infect Dis. 2007 Apr 1;44(7):968-71. Epub 2007 Feb 26.

PMID:
17342650
12.

Use of a real time PCR assay for detection of the ctxA gene of Vibrio cholerae in an environmental survey of Mobile Bay.

Blackstone GM, Nordstrom JL, Bowen MD, Meyer RF, Imbro P, DePaola A.

J Microbiol Methods. 2007 Feb;68(2):254-9. Epub 2006 Oct 10.

PMID:
17034889
13.

Real-time PCR quantification of Vibrio parahaemolyticus in oysters using an alternative matrix.

Kaufman GE, Blackstone GM, Vickery MC, Bej AK, Bowers J, Bowen MD, Meyer RF, DePaola A.

J Food Prot. 2004 Nov;67(11):2424-9.

PMID:
15553623
14.

Responding to detection of aerosolized Bacillus anthracis by autonomous detection systems in the workplace.

Meehan PJ, Rosenstein NE, Gillen M, Meyer RF, Kiefer MJ, Deitchman S, Besser RE, Ehrenberg RL, Edwards KM, Martinez KF.

MMWR Recomm Rep. 2004 Jun 4;53(RR-7):1-12.

15.

Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus.

Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, Meyer RF, Tong S, Cook BT, Holloway BP, McCaustland KA, Rota PA, Bankamp B, Lowe LE, Ksiazek TG, Bellini WJ, Anderson LJ.

Emerg Infect Dis. 2004 Feb;10(2):311-6.

16.

Iris-sutured posterior chamber intraocular lens implantation during penetrating keratoplasty.

Farjo AA, Rhee DJ, Soong HK, Meyer RF, Sugar A.

Cornea. 2004 Jan;23(1):18-28.

PMID:
14701953
17.

Detection of pathogenic Vibrio parahaemolyticus in oyster enrichments by real time PCR.

Blackstone GM, Nordstrom JL, Vickery MC, Bowen MD, Meyer RF, DePaola A.

J Microbiol Methods. 2003 May;53(2):149-55.

PMID:
12654486
18.

Phacoemulsification in eyes with corneal opacification.

Farjo AA, Meyer RF, Farjo QA.

J Cataract Refract Surg. 2003 Feb;29(2):242-5.

PMID:
12648631
19.

Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis.

Hoffmaster AR, Meyer RF, Bowen MD, Marston CK, Weyant RS, Thurman K, Messenger SL, Minor EE, Winchell JM, Rassmussen MV, Newton BR, Parker JT, Morrill WE, McKinney N, Barnett GA, Sejvar JJ, Jernigan JA, Perkins BA, Popovic T.

Emerg Infect Dis. 2002 Oct;8(10):1178-82. No abstract available. Erratum in: Emerg Infect Dis. 2003 Apr;9(4):511.

20.

Bioterrorism-related anthrax surveillance, Connecticut, September-December, 2001.

Williams AA, Parashar UD, Stoica A, Ridzon R, Kirschke DL, Meyer RF, McClellan J, Fischer M, Nelson R, Cartter M, Hadler JL, Jernigan JA, Mast EE, Swerdlow DL; Connecticut Anthrax Investigation Team.

Emerg Infect Dis. 2002 Oct;8(10):1078-82.

21.

First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001.

Traeger MS, Wiersma ST, Rosenstein NE, Malecki JM, Shepard CW, Raghunathan PL, Pillai SP, Popovic T, Quinn CP, Meyer RF, Zaki SR, Kumar S, Bruce SM, Sejvar JJ, Dull PM, Tierney BC, Jones JD, Perkins BA; Florida Investigation Team.

Emerg Infect Dis. 2002 Oct;8(10):1029-34.

22.

Detection of Bacillus anthracis DNA by LightCycler PCR.

Bell CA, Uhl JR, Hadfield TL, David JC, Meyer RF, Smith TF, Cockerill FR 3rd.

J Clin Microbiol. 2002 Aug;40(8):2897-902.

23.

Bioterrorism preparedness for the public health and medical communities.

Meyer RF, Morse SA.

Mayo Clin Proc. 2002 Jul;77(7):619-21. No abstract available.

PMID:
12108597
24.

Detection of smallpox virus DNA by LightCycler PCR.

Espy MJ, Cockerill III FR, Meyer RF, Bowen MD, Poland GA, Hadfield TL, Smith TF.

J Clin Microbiol. 2002 Jun;40(6):1985-8. Erratum in: J Clin Microbiol 2002 Nov;40(11):4405.

25.

Foot-and-mouth disease: a review of the virus and the symptoms.

Meyer RF, Knudsen RC.

J Environ Health. 2001 Nov;64(4):21-3.

PMID:
11936028
26.

A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia.

Bowen MD, Trappier SG, Sanchez AJ, Meyer RF, Goldsmith CS, Zaki SR, Dunster LM, Peters CJ, Ksiazek TG, Nichol ST; RVF Task Force.

Virology. 2001 Dec 20;291(2):185-90.

27.

Diamond burr superficial keratectomy for recurrent corneal erosions.

Soong HK, Farjo Q, Meyer RF, Sugar A.

Br J Ophthalmol. 2002 Mar;86(3):296-8.

28.

Fatal inhalational anthrax in a 94-year-old Connecticut woman.

Barakat LA, Quentzel HL, Jernigan JA, Kirschke DL, Griffith K, Spear SM, Kelley K, Barden D, Mayo D, Stephens DS, Popovic T, Marston C, Zaki SR, Guarner J, Shieh WJ, Carver HW 2nd, Meyer RF, Swerdlow DL, Mast EE, Hadler JL; Anthrax Bioterrorism Investigation Team.

JAMA. 2002 Feb 20;287(7):863-8.

PMID:
11851578
29.

Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, Tapper M, Fisk TL, Zaki S, Popovic T, Meyer RF, Quinn CP, Harper SA, Fridkin SK, Sejvar JJ, Shepard CW, McConnell M, Guarner J, Shieh WJ, Malecki JM, Gerberding JL, Hughes JM, Perkins BA; Anthrax Bioterrorism Investigation Team.

Emerg Infect Dis. 2001 Nov-Dec;7(6):933-44.

30.

Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.

Saijo M, Niikura M, Morikawa S, Ksiazek TG, Meyer RF, Peters CJ, Kurane I.

J Clin Microbiol. 2001 Jan;39(1):1-7.

31.

Small, overlapping tectonic keratoplasty involving graft-host junction of penetrating keratoplasty.

Soong HK, Meyer RF, Sugar A.

Am J Ophthalmol. 2000 Apr;129(4):465-7.

PMID:
10764854
32.

Lamellar corneal patch grafts in the management of corneal melting.

Soong HK, Farjo AA, Katz D, Meyer RF, Sugar A.

Cornea. 2000 Mar;19(2):126-34.

PMID:
10746441
33.

A universal virus inactivant for decontaminating blood and biopharmaceutical products.

Brown F, Meyer RF, Law M, Kramer E, Newman JF.

Dev Biol Stand. 1999;99:119-30.

PMID:
10404883
34.

Central lamellar keratoplasty for optical indications.

Soong HK, Katz DG, Farjo AA, Sugar A, Meyer RF.

Cornea. 1999 May;18(3):249-56.

PMID:
10336023
36.

Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations.

Lubroth J, López A, Ramalho AK, Meyer RF, Brown F, Darsie GC.

Vet Q. 1998;20 Suppl 2:S13-7.

PMID:
9652056
37.

Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins.

Mezencio JM, Babcock GD, Meyer RF, Lubroth J, Salt JS, Newman JF, Brown F.

Vet Q. 1998;20 Suppl 2:S11-3.

PMID:
9652055
38.

A universal virus inactivant for decontaminating blood and biopharmaceutical products.

Brown F, Meyer RF, Law M, Kramer E, Newman JF.

Biologicals. 1998 Mar;26(1):39-47.

PMID:
9637748
39.

Cattle response to foot-and-mouth disease virus nonstructural proteins as antigens within vaccines produced using different concentrations.

Lubroth J, López A, Ramalho AK, Meyer RF, Brown F, Darsie GC.

Vet Q. 1998 May;20(sup2):13-17.

PMID:
22077290
40.

Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteins.

Mezencio JM, Babcock GD, Meyer RF, Lubroth J, Salt JS, Newman JF, Brown F.

Vet Q. 1998 May;20(sup2):11-13.

PMID:
22077289
41.

The utility of culturing corneal ulcers in a tertiary referral center versus a general ophthalmology clinic.

Rodman RC, Spisak S, Sugar A, Meyer RF, Soong HK, Musch DC.

Ophthalmology. 1997 Nov;104(11):1897-901.

PMID:
9373123
42.

Assessment of health-related quality of life after corneal transplantation.

Musch DC, Farjo AA, Meyer RF, Waldo MN, Janz NK.

Am J Ophthalmol. 1997 Jul;124(1):1-8.

PMID:
9222225
43.

Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals.

Meyer RF, Babcock GD, Newman JF, Burrage TG, Toohey K, Lubroth J, Brown F.

J Virol Methods. 1997 Apr;65(1):33-43.

PMID:
9128860
44.
45.

Localization of foot and mouth disease virus RNA in tissue culture infected cells via in situ polymerase chain reaction.

Prato Murphy ML, Rodriguez M, Schudel AA, Meyer RF.

J Virol Methods. 1995 Aug;54(2-3):173-8.

PMID:
8530568
47.

Pathogenesis of foot-and-mouth disease in swine, studied by in-situ hybridization.

Brown CC, Olander HJ, Meyer RF.

J Comp Pathol. 1995 Jul;113(1):51-8.

PMID:
7490337
48.

NaK-ATPase pump sites in cultured bovine corneal endothelium of varying cell density at confluence.

Crawford KM, Ernst SA, Meyer RF, MacCallum DK.

Invest Ophthalmol Vis Sci. 1995 Jun;36(7):1317-26.

PMID:
7775109
49.

Presence of African horse sickness virus in equine tissues, as determined by in situ hybridization.

Brown CC, Meyer RF, Grubman MJ.

Vet Pathol. 1994 Nov;31(6):689-94.

PMID:
7863585
50.

Interleukin-10 inhibition of HLA-DR expression in human herpes stromal keratitis.

Boorstein SM, Elner SG, Meyer RF, Sugar A, Strieter RM, Kunkel SL, Elner VM.

Ophthalmology. 1994 Sep;101(9):1529-35.

PMID:
7916449

Supplemental Content

Loading ...
Support Center